Hyperopia Insights and Trends

• According to DelveInsight estimates, approximately 91 million prevalent cases of hyperopia were reported across the 7MM in 2025, of which nearly 17 million cases were in the US. The disease burden in the US is anticipated to rise due to demographic aging, given the higher prevalence of hyperopia among older adults.
• Hyperopia is increasingly recognized as a public health concern in children, as uncorrected refractive errors may negatively affect educational performance, visual development, and overall quality of life.
• The epidemiology of hyperopia varies considerably by age, and geographic region, highlighting the importance of population-specific screening and disease burden assessments.
• Under diagnosis of latent hyperopia remains a significant unmet need, particularly in children and younger adults, as accommodation can mask refractive error during routine eye examinations which can delay diagnosis.

Hyperopia Epidemiology Forecast in the 7MM

• 2025 Prevalent Cases of Hyperopia: ~91 million
• 2036 Projected Prevalent Cases of Hyperopia: ~XX
• Hyperopia Growth Rate (2026–2036): XX% CAGR

DelveInsight's ‘Hyperopia Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the GCA, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Hyperopia Understanding and Diagnosis Algorithm

Hyperopia Overview

Hyperopia (farsightedness) is a common refractive error in which light focuses behind the retina, resulting in difficulty seeing nearby objects clearly while distance vision may remain relatively unaffected. The condition is typically caused by a shortened axial length of the eye or insufficient refractive power of the cornea and lens. Although mild hyperopia can be compensated through accommodation, moderate-to-severe hyperopia may lead to blurred vision, eyestrain, headaches, and reading difficulties. In children, uncorrected hyperopia can increase the risk of amblyopia and accommodative esotropia.

Further details are provided in the report...

Hyperopia Diagnosis

Hyperopia is diagnosed through a comprehensive eye examination that includes visual acuity assessment and refraction testing to determine the degree of refractive error. Because accommodation can mask hyperopia, particularly in children and young adults, cycloplegic refraction is considered the gold-standard diagnostic method for accurately identifying the condition. Additional evaluation of ocular alignment and binocular vision may be performed to detect associated complications such as amblyopia and accommodative esotropia, while a comprehensive ocular examination helps exclude underlying eye disorders. Key diagnostic tests can include visual acuity testing, objective and subjective refraction, cycloplegic refraction, ocular alignment assessment, and comprehensive ocular examination.

Further details are provided in the report...

Hyperopia Epidemiology

The Hyperopia epidemiology section offers comprehensive insights into the historical, current, and projected patient population across the seven major markets (7MM). It examines the factors influencing existing and future epidemiological trends through an analysis of published studies and expert perspectives from key opinion leaders. Additionally, this section presents data on the diagnosed patient population, highlights evolving trends over time, and outlines the assumptions used in forecasting the Hyperopia patient pool.

Key Findings from Hyperopia Epidemiological Analysis and Forecast

• According to DelveInsight estimates, the United States accounted for ~17 million prevalent cases of hyperopia, representing 18% of the total prevalent cases across the 7MM.
• Among all age groups in the United States, individuals aged 60–69 years represented the largest prevalent hyperopia population in 2025.
• Overall prevalence of hyperopia is around 10%, approximately 14 million people, in the United States. Most full-term infants are mildly hyperopic. By age 6-9 months approximately 4-9% of infants are hyperopic and by age 12 months the prevalence is approximately 3.6%.
• Within the EU4 and the UK, Germany represented the highest number of prevalent hyperopia population in 2025, while Spain had the lowest number of prevalent cases.
• The prevalence of hyperopia in Spain population (35.6%) increased with age, from 36.9% (3-8 years) to 55.8% (66-93 years).

Scope of the Report

• The report covers a segment of a descriptive overview of hyperopia, explaining their causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Explore comprehensive insights into the Hyperopia market insights, epidemiology, emerging therapies, competitive landscape, and 2034 forecasts to stay ahead of industry trends.

Hyperopia Epidemiology Report Insights

• Hyperopia Patient Population Forecast

Report Key Strengths

• Epidemiology based (Epi based) Bottom up Forecasting
• 11-year Forecast
• Patient Burden Trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of hyperopia? What will be the growth opportunities across the 7MM concerning the patient population with hyperopia?
• What is the historical and forecasted hyperopia patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy Hyperopia Epidemiology Reports

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.